Subject | Dose | PABA Recovery | Urinary Drug Excretion | ΔCu | ΔZn | ||||
---|---|---|---|---|---|---|---|---|---|
TETA | MAT | DAT | |||||||
mg | % | μmol/day | μmol/day | ||||||
HV1 | 300 | 119 | 3.34 | 22.4 | 9.45 | 1.35 | 2.19 | ||
600 | 33.8 | 0.183 | 6.28 | 14.6 | 0.096 | -0.834 | |||
1200 | 101 | 11.9 | 51.7 | 17.3 | 1.75 | 6.88 | |||
2400 | 85.8 | 70.6 | 97.4 | 63.7 | 4.24 | 17.0 | |||
HV2 | 300 | 123 | 14.8 | 54.0 | 20.5 | 1.47 | 2.63 | ||
600 | 110 | 11.9 | 27.9 | 7.16 | 1.55 | 6.20 | |||
1200 | 100 | 45.7 | 52.7 | 16.1 | 3.99 | 22.4 | |||
2400 | 122 | 267 | 1037 | 165 | 8.62 | 59.5 | |||
HV3 | 300 | 85.9 | <LLOQ | <LLOQ | 1.78 | 0.53 | 0.86 | ||
600 a | 14.2 | 0.463 | 1.18 | 0.322 | -0.346 | ||||
1200 | 1.25 | 24.3 | 40.1 | 15.2 | 3.17 | 14.3 | |||
2400 | 97.6 | 111 | 149 | 65.9 | 5.29 | 39.2 | |||
HV4 | 300 | 80.3 | 0.288 | 0.050 | 0.165 | 0.455 | 1.74 | ||
600 | 143 | 0.072 | 0.785 | 0.066 | 1.69 | 2.08 | |||
1200 | 107 | 20.2 | 37.3 | 24.2 | 3.40 | 6.26 | |||
2400 | 96.7 | 164 | 228 | 93.0 | 7.66 | 26.6 | |||
HV5 | 300 | -1.56 | <LLOQ | <LLOQ | <LLOQ | -0.032 | -1.04 | ||
600 | 33.1 | <LLOQ | <LLOQ | <LLOQ | 0.243 | 1.31 | |||
1200 | 60.9 | 31.9 | 360 | 57.6 | 1.98 | 9.60 | |||
2400 | 59.6 | <LLOQ | <LLOQ | <LLOQ | 0.004 | 0.627 | |||
HV6 | 300 | 79.4 | <LLOQ | <LLOQ | <LLOQ | 0.136 | 1.83 | ||
600 | 72.0 | <LLOQ | <LLOQ | <LLOQ | 0.935 | 2.45 | |||
1200 | 97.2 | 2.36 | 28.6 | 72.7 | 1.30 | 4.12 | |||
|
2400
|
35.1
| <LLOQ | <LLOQ | <LLOQ |
-0.223
|
-8.08
|
HV, healthy volunteer.
↵ a Italicized numbers represent excluded data points.